
Leading UK oncologists have written an article in the May issue of The Lancet, strongly urging Britain to remain in …

Opdivo (nivolumab) showed the biggest increase in survival for patients with head and neck cancer for 20 years, according to …

Bristol-Myers Squibb has announced that its potentially life-extending cancer immunotherapy, Opdivo (nivolumab), has been approved by the European Commission to …

Shares in oncology-focussed Tesaro Inc (Nasdaq: TSRO) jumped Wednesday after the company said pharma major Johnson & Johnson (NYSE: JNJ) …

The US FDA has approved Pfizer’s supplemental new drug application (sNDA) for its kinase inhibitor Xalkori in treating patients with …

Israeli generics giant Teva has announced it will support IVF-Worldwide with a research grant to improve knowledge of fertility preservation …

Shares in Celldex Therapeutics (Nasdaq: CLDX) more than halved in value on the Nasdaq Monday as the company said independent regulators …

Merck has announced that it has entered into a research collaboration with the European Molecular Biology Laboratory (EMBL), that will …

Janssen, the R&D arm of pharma major Johnson & Johnson, says it is extremely disappointed following regulator NICE’s announcement that …

Exelixis has signed a licensing agreement with French biotech firm Ipsen for its cancer drug Cometriq (cabozantinib) for an upfront …

Irish regulators have recommended two cancer treatments from Celgene: Imnovid (pomalidomide), in combination with dexamethasone, for previously-treated relapsed and refractory …

AstraZeneca and its global biologics research and development arm, MedImmune, have announced a setback in the result of their Phase …

Scientists have developed a test for cancer that can diagnose the disease at home with the aid of just a …

Germany’s Merck celebrated World Cancer Day by collaborating with the Uganda Ministry of Health to raise awareness about early detection …

Cancer is one of the greatest health challenges of our time, and a leading cause of death in every corner …